Leyla MOLLAMAHMUTOĞLU, Runa ÖZELÇİ, Funda AKPINAR, Zeynep KOTAN, Derya AKDAĞ CİRİK, Sezin AKSAKAL, Berna DİLBAZ

Do anxiety and depression statuses differ in different polycystic ovary syndrome phenotypes?

Background/aim: To evaluate psychological parameters and health quality profiles in women with reproductive polycystic ovary syndrome (PCOS) phenotypes and age matched controls. Materials and methods: The study groups included 101 women with PCOS (54 with the National Institutes of Health [NIH] phenotype and 47 with the non-NIH phenotype) and 49 healthy female controls. The participants completed anxiety and depression scales and four quality of life domains. Results: We identified the women with PCOS as having a 3.39 times increased risk for depression (subscale ≥ 7) and a 3.64 times increased risk for anxiety (subscale ≥ 10) compared to the controls. Both NIH and non-NIH phenotypes showed similar rates of depression (46.3% vs. 46.8%, respectively; P = 0.57) and anxiety (31.5% vs. 36.2%, respectively; P = 0.47). Regarding the quality of life scale, the women with NIH PCOS had significantly lower mental health scores compared to those with non-NIH PCOS (P = 0.03). Furthermore, while mental health scores were similar in the women with PCOS and the controls, physical health scores were significantly lower in the women with PCOS (P = 0.007). Conclusion: Nearly half of the women with PCOS had higher depression scores and one third had higher anxiety scores. Thus, psychiatric evaluations appear necessary for PCOS patients in order to diagnose and treat clinical depression and anxiety

PDF

___

1. Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group, Consensus on womens health aspects of polycystic ovary syndrome (PCOS). Hum Reprod 2012; 27: 14-24.
2. Dokras A, Clifton S, Futterweit W, Wild R. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol 2011; 117: 145-152.
3. Dokras A. Mood and anxiety disorder in women with PCOS. Steroids 2012; 77: 338-341.
4. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome; toward a rational approach. In: Dunaif A, Givens JR, Haseltine FP, editors. Polycystic Ovary Syndrome. Boston, MA, USA: Blackwell Scientific 1992; pp. 377-384.
5. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47.
6. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25: 544-551.
7. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK; Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013; 98: 4565-4592.
8. Alpañés M, Luque-Ramírez M, Martínez-García MÁ, Fernández-Durán E, Álvarez-Blasco F, Escobar-Morreale HF. Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome. Fertil Steril 2015; 103: 795-801.
9. Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod 2012; 27: 3067-3073.
10. Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010; 16: 347-363.
11. Daan NM, Louwers YV, Koster MP, Eijkemans MJ, de Rijke YB, Lentjes EW, Fauser BC, Laven JS. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? Fertil Steril 2014; 102: 1444-1451.
12. Moran LJ, Deeks AA, Gibson-Helm ME, Teede HJ. Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod 2012; 27: 2082-2088.
13. Klimczak D, Szlendak-Sauer K, Radowicki S. Depression in relation to biochemical parameters and age in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2015; 184: 43-47.
14. Aydemir O. Validity and reliability of Turkish version of hospital anxiety and depression scale. Turk Psikiyatri Dergisi 1997; 8: 280-287 (article in Turkish with an abstract in English).
15. Development of the World Health Organization WHOQOLBREF quality of life assessment. The WHOQOL Group. Psychol Med 1998; 28: 551-558.
16. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties Soc Sci Med 1998; 46: 1569-1585.
17. Eser E FH, Fidaner C. WHOQOL-BREF TR: a suitable instrument for the assessment of quality of life for use in the health care settings in Turkey. Quality of Life Research 1999; 8: 647.
18. Moran L, Gibson-Helm M, Teede H, Deeks A. Polycystic ovary syndrome: a biopsycholosocial understanding in young women to improve knowledge and treatment options. J Psychosom Obstet Gynaecol 2010; 1: 24-31.
19. Hung JH, Hu LY, Tsai SJ, Yang AC, Huang MW, Chen PM, Wang SL, Lu T, Shen CC. Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study. PLoS One 2014; 9: e97041.
20. Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril 2010; 93: 2421-2423.
21. Cinar N, Kizilarslanoglu MC, Harmanci A, Aksoy DY, Bozdag G, Demir B, Yildiz BO. Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum Reprod 2011; 26: 3339-3345.
22. Krępuła K, Bidzińska-Speichert B, Lenarcik A, TworowskaBardzińska U. Psychiatric disorders related to polycystic ovary syndrome. Endokrynol Pol 2012; 63: 488-91.
23. Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Kazemnejad A, Faghihzadeh S. Predictive factors of healthrelated quality of life in patients with polycystic ovary syndrome: a structural equation modeling approach. Fertil Steril 2013; 100: 1389-1396.
24. Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Faghihzadeh S. Health-related quality of life and its relationship with clinical symptoms among Iranian patients with polycystic ovarian syndrome. Iran J Reprod Med 2013; 11: 371-378.
25. Livadas S, Chaskou S, Kandaraki AA, Skourletos G, Economou F, Christou M, Boutzios G, Karachalios A, Zerva A, Xyrafis X et al. Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome. Clin Endocrinol (Oxf) 2011; 75: 698-703.
26. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8: 41.
27. Rahiminejad ME, Moaddab A, Rabiee S, Esna-Ashari F, Borzouei S, Hosseini SM. The relationship between clinicobiochemical markers and depression in women with polycystic ovary syndrome. Iran J Reprod Med 2014; 12: 811- 816.
28. Weber B, Lewicka S, Deuschle M, Colla M, Heuser I. Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression. Psychoneuroendocrinology 2000; 25: 765-771.
29. Baischer W, Koinig G, Hartmann B, Huber J, Langer G. Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology 1995; 20: 553-559.
30. Weiner CL, Primeau M, Ehrmann DA. Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom Med 2004; 66: 356-362.
31. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 2007; 87: 1369-1376.
32. Bhattacharya SM, Jha A. Prevalence and risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 2010; 94: 357-359.
33. Dilbaz B, Çınar M, Özkaya E, Tonyalı NV, Dilbaz S. Health related quality of life among different PCOS phenotypes of infertile women. J Turk Ger Gynecol Assoc 2012; 13: 247-245.
34. Månsson M, Holte J, Landin-Wilhelmsen K, Dahlgren E, Johansson A, Landén M. Women with polycystic ovary syndrome are often depressed or anxiousa case control study. Psychoneuroendocrinology 2008; 33: 1132-1138.